• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6,132
2,057
1,970
1,632
1,446

COUNTRY

1,009
795
248
216
175

CATEGORIES

  • 933
  • 177
  • 112
  • 321
    • 55
  • 468
  • 238
  • 237
  • 47
  • 67
  • 799
  • 1,425
  • 840
  • 17
  • 444
  • 1,361
  • 2,287
    • 82
    • 121
    • 66
    • 66
    • 36
    • 37
    • 12
    • 11
    • 12
    • 18
  • 23
  • 259
  • 44

PRICE

5,702
12,877
20,459
25,783

PUBLISHED

3,790
5,217
10,125
25,783

PRODUCT TYPE

21,644
1,955
1,006
910
164
38
21
19
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014 Summary This, ‘Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2014’, provides an overview of the Vaginal Atrophy (Atrophic...

August 2014
FROM

Retinal Vein Occlusion - Pipeline Review, H2 2014

Retinal Vein Occlusion - Pipeline Review, H2 2014 Summary This, ‘Retinal Vein Occlusion - Pipeline Review, H2 2014’, provides an overview of the Retinal Vein Occlusion’s therapeutic pipeline. This...

August 2014
FROM

Allergic Conjunctivitis - Pipeline Review, H2 2014

Allergic Conjunctivitis - Pipeline Review, H2 2014 Summary This, ‘Allergic Conjunctivitis - Pipeline Review, H2 2014’, provides an overview of the Allergic Conjunctivitis’s therapeutic pipeline. This...

August 2014
FROM

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2014

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2014 Summary This, ‘Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2014’, provides an overview of the Herpes Labialis (Oral Herpes)’s therapeutic...

August 2014
FROM

Diabetic Neuropathy - Pipeline Review, H2 2014

Diabetic Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Diabetic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report...

August 2014
FROM

Severe Psoriasis - Pipeline Review, H2 2014

Severe Psoriasis - Pipeline Review, H2 2014 Summary This, ‘Severe Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides...

August 2014
FROM

Cachexia - Pipeline Review, H2 2014

Cachexia - Pipeline Review, H2 2014 Summary This, ‘Cachexia - Pipeline Review, H2 2014’, provides an overview of the Cachexia’s therapeutic pipeline. This report provides comprehensive information...

August 2014
FROM

Amyloidosis - Pipeline Review, H2 2014

Amyloidosis - Pipeline Review, H2 2014 Summary This, ‘Amyloidosis - Pipeline Review, H2 2014’, provides an overview of the Amyloidosis’s therapeutic pipeline. This report provides comprehensive information...

August 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

August 2014
FROM

Tourette Syndrome - Pipeline Review, H2 2014

Tourette Syndrome - Pipeline Review, H2 2014 Summary This, ‘Tourette Syndrome - Pipeline Review, H2 2014’, provides an overview of the Tourette Syndrome’s therapeutic pipeline. This report provides...

August 2014
FROM

Fracture - Pipeline Review, H2 2014

Fracture - Pipeline Review, H2 2014 Summary This, ‘Fracture - Pipeline Review, H2 2014’, provides an overview of the Fracture’s therapeutic pipeline. This report provides comprehensive information...

August 2014
FROM

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain...

August 2014
FROM

Perennial Allergic Rhinitis - Pipeline Review, H2 2014

Perennial Allergic Rhinitis - Pipeline Review, H2 2014 Summary This, ‘Perennial Allergic Rhinitis - Pipeline Review, H2 2014’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic...

August 2014
FROM

Glomerulonephritis - Pipeline Review, H2 2014

Glomerulonephritis - Pipeline Review, H2 2014 Summary This, ‘Glomerulonephritis - Pipeline Review, H2 2014’, provides an overview of the Glomerulonephritis’s therapeutic pipeline. This report provides...

August 2014
FROM

Mexico Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The lack of a unified reimbursement system, the absence of widespread private health insurance, relatively low healthcare spending and the promotion of generic drugs in Mexico will continue...

August 2014

Latvia Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Latvia's macroeconomic environment continues to improve at the same time as smooth transitions to a new currency and new Prime Minister. Market growth forecasts are strong although the country...

August 2014

Thailand Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Thailand offers several revenue earning opportunities to drugmakers due to its ageing population and the presence of a universal healthcare system that provides the population with access...

August 2014

Kenya Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Investment into Kenya's healthcare sector by pharmaceutical and medical device companies is an advisable business strategy - as highlighted by the high growth forecast in healthcare spending...

August 2014

Zambia Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The disparity between urban and rural healthcare provision in Zambia is showing signs of being addressed, with the recent opening of the first ever hospital to serve the district of Chienge....

August 2014

Algeria Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The Algerian government's aspirations to rebalance the pharmaceutical trade deficit and promote local generic production, whilst enhancing the country's competitiveness by stimulating the...

August 2014
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S